Despite lower forecast growth, the company's P/E ratio align...
Despite lower forecast growth, the company's P/E ratio aligns with most firms, suggesting investors are less bearish than analysts. However, if the P/E aligns with the growth outlook, shareholders may face disappointment. The weak earnings outlook and slower growth suggest share price risk.
Some Confidence Is Lacking In China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294) As Shares Slide 26%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment